14.12
price down icon3.49%   -0.51
after-market Dopo l'orario di chiusura: 14.12
loading

Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie

pulisher
04:48 AM

Edgewise Therapeutics, Inc. (EWTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

04:48 AM
pulisher
04:27 AM

What analysts say about Edgewise Therapeutics Inc. stockRapidly growing investment returns - PrintWeekIndia

04:27 AM
pulisher
11:24 AM

Jennison Associates LLC Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

11:24 AM
pulisher
12:56 PM

Readystate Asset Management LP Raises Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

12:56 PM
pulisher
Jul 24, 2025

Why Edgewise Therapeutics Inc. stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Edgewise Therapeutics Inc. stock priceRapid wealth accumulation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Edgewise Therapeutics, Inc. (EWTX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

Edgewise Therapeutics Inc. Stock Analysis and ForecastMarket-leading growth rates - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Becker Muscular Dystrophy Pipeline 2025: Key Companies, MOA, - openPR.com

Jul 24, 2025
pulisher
Jul 23, 2025

BlackRock, Inc. Reduces Stake in Edgewise Therapeutics Inc. - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Arizona State Retirement System - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Is Edgewise Therapeutics Inc. a good long term investmentConsistently superior profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edgewise Therapeutics, Inc. (EWTX) And Encourages Investors to Reach Out - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - MarketScreener

Jul 22, 2025
pulisher
Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - PR Newswire

Jul 22, 2025
pulisher
Jul 21, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edgewise Therapeutics, Inc. (EWTX) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 19, 2025

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

When is the best time to buy Edgewise Therapeutics Inc. stockSmart Growth Low Risk Picks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Edgewise Therapeutics Inc. stock price move sharplyQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Edgewise Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7.9%Time to Buy? - MarketBeat

Jul 12, 2025
pulisher
Jul 08, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jul 08, 2025
pulisher
Jul 07, 2025

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

(EWTX) Trading Report - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jul 03, 2025

User - FinancialContent

Jul 03, 2025
pulisher
Jul 01, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by HC Wainwright - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

HC Wainwright Initiates Edgewise Therapeutics With Buy Rating, $42 Price Target - MarketScreener

Jun 30, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):